Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?

• Published in: American journal of hematology Vol. 99; no. 1; pp. 48 - 56
• Main Authors: Ghergus, Dana, Martin, Mickaël, Knapp, Anne‐Marie, Delmotte, Fabien, Joublin‐Delavat, Aurélie, Jung, Sophie, Schickel, Jean‐Nicolas, Mendel, Isabelle, Dupuis, Arnaud, Drénou, Bernard, Ghesquières, Hervé, Salles, Gilles, Baseggio, Lucile, Herbrecht, Raoul, Korganow, Anne‐Sophie, Vallat, Laurent, Soulas‐Sprauel, Pauline, Meffre, Eric, Martin, Thierry
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.01.2024; Wiley Subscription Services, Inc; Wiley
• Subjects: Autoimmunity; B-Lymphocytes; CD5 antigen; Chronic lymphocytic leukemia; Flow Cytometry; Hematology; Humans; Immunoglobulins; Immunology; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemogenesis; Life Sciences; Lymphocytes B; Prognosis; ZAP-70 protein; ZAP-70 Protein-Tyrosine Kinase - genetics; ZAP-70 Protein-Tyrosine Kinase - metabolism
• ISSN: 0361-8609; 1096-8652; 1096-8652
• DOI: 10.1002/ajh.27137

ZAP70 has a prognostic value in chronic lymphocytic leukemia (CLL), through altered B‐cell receptor signaling, which is important in CLL pathogenesis. A good correlation between ZAP70 expression in CLL cells and the occurrence of autoimmune phenomena has been reported. Yet, the great majority of CLL‐associated autoimmune cytopenia is due to polyclonal immunoglobulin (Ig) G synthesized by nonmalignant B cells, and this phenomenon is poorly understood. Here, we show, using flow cytometry, that a substantial percentage of CD5‐ nonmalignant B cells from CLL patients expresses ZAP70 compared with CD5‐ B cells from healthy subjects. This ZAP70 expression in normal B cells from CLL patients was also evidenced by the detection of ZAP70 mRNA at single‐cell level with polyclonal Ig heavy‐ and light‐chain gene transcripts. ZAP70+ normal B cells belong to various B‐cell subsets and their presence in the naïve B‐cell subset suggests that ZAP70 expression may occur during early B‐cell development in CLL patients and potentially before malignant transformation. The presence of ZAP70+ normal B cells is associated with autoimmune cytopenia in CLL patients in our cohort of patients, and recombinant antibodies produced from these ZAP70+ nonmalignant B cells were frequently autoreactive including anti‐platelet reactivity. These results provide a better understanding of the implication of ZAP70 in CLL leukemogenesis and the mechanisms of autoimmune complications of CLL. Non‐malignant CD5‐ B cells from CLL patients express ZAP70. These ZAP70+CD5‐ B cells may be involved in the development of autoimmunity in CLL patients.